Diabetes and the metabolic syndrome--when is it best to intervene to prevent?

Atherosclerosis. Supplements
Steven M Haffner

Abstract

In addition to microvascular complications, patients with type 2 diabetes are at increased risk of cardiovascular disease (CVD) and mortality. An important initial step in reducing the overall burden of CVD, as well as other diabetes complications, is to prevent progression to diabetes in individuals at risk. A number of studies have indicated the increased presence of both established and emerging cardiovascular risk factors associated with the metabolic syndrome in individuals before the onset of diabetes. First-line therapy in the treatment of the metabolic syndrome risk factors is lifestyle intervention, which can be highly successful in preventing or delaying progression to overt diabetes, but on its own may not achieve and/or maintain adequate risk reduction. In this case, individuals need to be identified and treated with appropriate pharmacological interventions. The data are unequivocal in the importance of the timely identification of at-risk subjects, and implementation of effective treatment strategies, which could potentially reduce diabetes- and CVD-related morbidity and mortality.

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jan 1, 1996·Stroke; a Journal of Cerebral Circulation·S LehtoM Laakso
Feb 24, 2001·Annals of Internal Medicine·V J StevensUNKNOWN Trials for the Hypertension Prevention Research Group
Feb 28, 2001·Diabetes, Obesity & Metabolism·M Kobayashi
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 24, 2001·JAMA : the Journal of the American Medical Association·A D PradhanP M Ridker
Jan 30, 2002·Diabetes·Clifton Bogardus, P Antonio Tataranni
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Jun 28, 2002·Lancet·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trail Research Group
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Apr 30, 2003·Diabetes·Charles M AlexanderUNKNOWN National Cholesterol Education Program (NCEP)
Sep 19, 2003·Lancet·Marc A PfefferUNKNOWN CHARM Investigators and Committees

❮ Previous
Next ❯

Citations

Jun 26, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hirofumi TomiyamaAkira Yamashina
Jan 20, 2012·Diabetes Research and Clinical Practice·Janice S DormanMuin J Khoury
Feb 24, 2007·Trends in Endocrinology and Metabolism : TEM·Michal ArmoniEddy Karnieli
Aug 19, 2007·International Journal of Methods in Psychiatric Research·M Katherine ShearHans-Ulrich Wittchen
Feb 10, 2011·Annals of Nutrition & Metabolism·Sergio Muntoni, Sandro Muntoni
Dec 21, 2016·Journal of Ophthalmic & Vision Research·Zhale RajaviFaegheh Golbafian
Jan 1, 2013·SAGE Open Medicine·Melba S D'SouzaSamira Maroof

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.